This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cabodi, S. Articles by Defilippi, P. Search for Related Content PubMed PubMed Citation Articles by Cabodi, S. Articles by Defilippi, P.

p130Cas as a New Regulator of Mammary Epithelial Cell Proliferation, Survival, and HER2-Neu Oncogene–Dependent Breast Tumorigenesis

Departments of ¹ Genetics, Biology and Biochemistry and ² Clinical and Biological Science, University of Torino; ³ Center for Experimental Research and Medical Studies, Molinette Hospital; Departments of ⁴ Biomedical Sciences and Human Oncology, University of Torino, and ⁵ Pathology, Azienda Ospedaliera O.I.R.M. Sant'Anna, Turin, Italy; ⁶ UMR 144, Centre National de la Recherche Scientifique Institute Curie Section de Recherche 26, Paris, France; and ⁷ Molecular Biotechnology Center, University of Torino, Torino, Italy

Requests for reprints: Paola Defilippi, Department of Genetics, Biology and Biochemistry, University of Torino, Via Santena, 5 bis 10126 Turin, Italy. Phone: 39-0116705858; Fax: 39-0116705853; E-mail: paola.defilippi{at}unito.it.

To investigate the mechanisms through which p130Cas adaptor protein is linked to tumorigenesis, we generated mouse mammary tumor virus (MMTV)-p130Cas mice overexpressing p130Cas in the mammary gland. MMTVp130Cas transgenic mice are characterized by extensive mammary epithelial hyperplasia during development and pregnancy and by delayed involution at the end of lactation. These phenotypes are associated with activation of Src kinase, extracellular signal-regulated kinase 1/2, mitogen-activated protein kinase, and Akt pathways, leading to an increased rate of proliferation and a decreased apoptosis. A double-transgenic line derived from crossing MMTV-p130Cas with MMTV-HER2-Neu mice expressing the activated form of the HER2-Neu oncogene develops multifocal mammary tumors with a significantly shorter latency than the HER2-Neu parental strain alone. Mammary epithelial cells isolated from tumors of double-transgenic mice display increased tyrosine phosphorylation, c-Src, and Akt activation compared with cells derived from HER2-Neu tumors. In addition, p130Cas down-regulation by RNA interference increases apoptosis in HER2-Neu-expressing cells, indicating that p130Cas regulates cell survival. Consistently with the double-transgenic mice model, p130Cas is overexpressed in a significant subset of human breast cancers and high levels of p130Cas in association with HER2 expression correlate with elevated proliferation. These findings provide evidences for a role of p130Cas as a positive regulator of both proliferation and survival in normal and transformed mammary epithelial cells. Its overexpression contributes to HER2-Neu-induced breast tumorigenesis, thus identifying this protein as a putative target for clinical therapy. (Cancer Res 2006; 66(9): 4672-80)

This article has been cited by other articles:

				E. Izumchenko, M. K. Singh, O. V. Plotnikova, N. Tikhmyanova, J. L. Little, I. G. Serebriiskii, S. Seo, M. Kurokawa, B. L. Egleston, A. Klein-Szanto, et al. NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development Cancer Res., September 15, 2009; 69(18): 7198 - 7206. [Abstract] [Full Text] [PDF]

				H. Q. Ta, K. S. Thomas, R. S. Schrecengost, and A. H. Bouton A Novel Association between p130Cas and Resistance to the Chemotherapeutic Drug Adriamycin in Human Breast Cancer Cells Cancer Res., November 1, 2008; 68(21): 8796 - 8804. [Abstract] [Full Text] [PDF]

				H. W. Smith, P. Marra, and C. J. Marshall uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180 J. Cell Biol., August 25, 2008; 182(4): 777 - 790. [Abstract] [Full Text] [PDF]

				C. Nyalendo, E. Beaulieu, H. Sartelet, M. Michaud, N. Fontaine, D. Gingras, and R. Beliveau Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice Carcinogenesis, August 1, 2008; 29(8): 1655 - 1664. [Abstract] [Full Text] [PDF]

				S. Daouti, W.-h. Li, H. Qian, K.-S. Huang, J. Holmgren, W. Levin, L. Reik, D. L. McGady, P. Gillespie, A. Perrotta, et al. A Selective Phosphatase of Regenerating Liver Phosphatase Inhibitor Suppresses Tumor Cell Anchorage-Independent Growth by a Novel Mechanism Involving p130Cas Cleavage Cancer Res., February 15, 2008; 68(4): 1162 - 1169. [Abstract] [Full Text] [PDF]

				Y. Chen, L.-Y. Choong, Q. Lin, R. Philp, C.-H. Wong, B.-K. Ang, Y.-L. Tan, M.-C.-S. Loh, C.-L. Hew, N. Shah, et al. Differential Expression of Novel Tyrosine Kinase Substrates during Breast Cancer Development Mol. Cell. Proteomics, December 1, 2007; 6(12): 2072 - 2087. [Abstract] [Full Text] [PDF]

				A. Di Florio, G. Capurso, M. Milione, F. Panzuto, R. Geremia, G. D. Fave, and C. Sette Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells Endocr. Relat. Cancer, March 1, 2007; 14(1): 111 - 124. [Abstract] [Full Text] [PDF]